Scheme 1. Synthesis of anti,syn Trifluoroamino Acid 15
Figure 1. Fluorination affects molecular conformation (1À3);
this concept is exploited by 4a/b which have shape-dependent
biological activity. Structure 5 is a target of this work.
stereoisomers of 4 have different preferred conformations,
and this has led to applications of 4a/b as subtype-selective
GABA receptor ligands and as components of shape-
9
controlled peptides.
In a conceptual extension of this work, we recently
became interested in the hypothetical R,β,γ-trifluoro-δ-
aminopentanoic acid structure (5, Figure 1). We recog-
nized that if such a δ-amino acid were incorporated into a
peptide, it would preserve the same backbone length as
a dipeptide of R-amino acids. At the same time, a peptide
containing 5 could showcase all of the stereoelectronic
effects outlined in Figure 1 (i.e., structures 1À3) within the
same molecule. The presence of three vicinal stereocenters
should allow several different isomers (and hence, several
different molecular shapes) to be created, with potential
applications as, for example, β-turn elements in bioactive
peptidomimetics. For these reasons, we were motivated to
attempt a synthesis of some of the stereoisomers of 5.
We reasoned that the trifluoro moiety of 5 could poten-
tially be created via a sequential nucleophilic deoxyfluor-
ination approach (Figure 1), based on methods developed
by O’Hagan and co-workers for the synthesis of other
multivicinal fluoroalkane systems in which the fluoroalkyl
moieties are flanked by alkyl, arylalkyl, or tosylate
could serve as a latent carboxylic acid until the end of the
4a,8,12
synthesis.
Finally, variation of the stereochemistry of 7
should allow different isomers of 5 to be created.
We initially targeted the anti,syn diastereoisomer 15
Scheme 1). Cross-metathesis of the enantiopure allylic
(
1
3
alcohol 8 with excess N-allylphthalimide delivered the
disubstituted alkene 9 in good yield and exclusively as the
1
4
E isomer. Asymmetric epoxidation of 9 then furnished
the epoxy alcohol 10 in good yield and with a diastereoiso-
meric ratio of greater than 99:1. The stage was now set for
10 to undergo three sequential nucleophilic fluorination
reactions. The first fluorination was performed by treat-
1
0
ing 10 with bis(2-methoxyethyl)aminosulfur trifluoride
(DeoxoFluor), and this delivered the benzylic fluoride 11
in excellent yield. Benzylic deoxyfluorination reactions are
often challenging due to competing S 2 and S 1 reaction
mechanisms, but in this case the presence of an aryl nitro
N
N
1
5
group, along with the additive TMS-morpholine, ensured
that the S 1 mechanism was suppressed and the fluorina-
10,11
N
groups.
Thus, an epoxy alcohol (7) could be subjected
tion occurred with clean inversion of stereochemistry.
The second fluorination reaction (11f12, Scheme 1)
was also challenging, due to the forcing conditions re-
quired to effect epoxide ring-opening. After considerable
optimization, we found that treatment of 11 with neat tri-
ethylamine trihydrofluoride under microwave irradiation
to deoxyfluorination, followed by epoxide opening with
fluoride, followed by deoxyfluorination of the newly formed
alcohol group, to deliver the required vicinal trifluoro
moiety (6). Meanwhile, we reasoned that the amino group
of 5 should be protected throughout, and that an aryl group
(
9) (a) Yamamoto, I.; Jordan, M. J. T.; Gavande, N.; Doddareddy,
(12) Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune,
H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765.
(13) (a) Stambasky, J.; Malkov, A. V.; Kocovsky, P. J. Org. Chem.
2008, 73, 9148. (b) George, S.; Narina, S. V. Tetrahedron 2006, 62, 10202.
(14) Carlsen, P. H. J.; Katsuki, T.; Martin, V. S.; Sharpless, K. B.
J. Org. Chem. 1981, 46, 3936.
(15) (a) Bio, M. M.; Waters, M.; Javadi, G.; Song, Z. J.; Zhang, F.;
Thomas, D. Synthesis 2008, 891. (b) Bresciani, S.; O’Hagan, D. Tetra-
hedron Lett. 2010, 51, 5795.
M. R.; Chebib, M.; Hunter, L. Chem. Commun. 2012, 48, 829. (b)
Hunter, L.; Butler, S.; Ludbrook, S. B. Org. Biomol. Chem. 2012, 10,
8
911. (c) Hunter, L. Chim. Oggi 2012, 30, 20.
10) Brunet, V. A.; Slawin, A. M. Z.; O’Hagan, D. Beilstein J. Org.
Chem. 2009, DOI: 10.3762/bjoc.5.61.
11) (a) Hunter, L.; O’Hagan, D. Org. Biomol. Chem. 2008, 6, 2843.
b) Nicoletti, M.; O’Hagan, D.; Slawin, A. M. Z. J. Am. Chem. Soc. 2005,
27, 482.
(
(
(
1
Org. Lett., Vol. 15, No. 21, 2013
5563